But as far as proceeding from LAVENDER to LILAC the situation is far more complex due to the double blinedness of the trial. Many combinations of factors would contribute to influencing whether to proceed or not.
The greatest 'muddying' factor would be the 'strength' of the 'placebo effect' in this particular trial. After all this effect is basically mind over matter and has the potential to affect both control and experimental arms - it can be strong or weak and is naturally duration dependent.
NEU Price at posting:
$2.08 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)